Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Myocardial Infarction Remodeling Prevention Therapy

NCT01213251 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01213251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Myocardial Infarction Remodeling Prevention Therapy
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2010
Completion date
April 30, 2016
Enrollment
129 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, cardiac remodeling, heart failure, pacing therapy